155 related articles for article (PubMed ID: 24909845)
21. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
22. Involved and Uninvolved Psoriatic Keratinocytes Display a Resistance to Apoptosis that may Contribute to Epidermal Thickness.
Eding CB; Enerbäck C
Acta Derm Venereol; 2017 Jul; 97(7):788-796. PubMed ID: 28350039
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy.
Rossi MT; Venturini M; Zanca A; Arisi M; Fusano M; Sottini A; Serana F; Imberti L; Calzavara-Pinton P
G Ital Dermatol Venereol; 2018 Feb; 153(1):1-4. PubMed ID: 28704992
[TBL] [Abstract][Full Text] [Related]
24. Epidermal changes during UVB phototherapy assessed by multiphoton laser tomography.
Koehler MJ; Kellner K; Kaatz M; Hipler UC
Skin Res Technol; 2016 Nov; 22(4):437-442. PubMed ID: 26853735
[TBL] [Abstract][Full Text] [Related]
25. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
Asawanonda P; Amornpinyokeit N; Nimnuan C
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
[TBL] [Abstract][Full Text] [Related]
26. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?
Pugashetti R; Lim HW; Koo J
J Dermatolog Treat; 2010 Nov; 21(6):326-30. PubMed ID: 19895327
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 9 promoter polymorphism as a predictive factor of narrow-band UVB phototherapy response in patients with psoriasis.
Romaní J; Julià M; Lozano F; Muñoz-Santos C; Guilabert A; Carrascosa JM; Rigla M; Luelmo J
Photodermatol Photoimmunol Photomed; 2015 Mar; 31(2):98-103. PubMed ID: 25561051
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of psoriasis vulgaris with targeted narrow-band ultraviolet B therapy using a new flat-type fluorescent lamp.
Nishida E; Furuhashi T; Kato H; Kaneko N; Shintani Y; Morita A
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):248-50. PubMed ID: 21950629
[TBL] [Abstract][Full Text] [Related]
29. A comparative non randomized study of narrow-band (NB) (312 +/- 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris.
Calzavara-Pinton P; Leone G; Venturini M; Sala R; Colombo D; La Parola IL; Sitzia N; Ferraro C; Picardo M
Eur J Dermatol; 2005; 15(6):470-3. PubMed ID: 16280301
[TBL] [Abstract][Full Text] [Related]
30. Correlation between Reversal of DNA Methylation and Clinical Symptoms in Psoriatic Epidermis Following Narrow-Band UVB Phototherapy.
Gu X; Nylander E; Coates PJ; Fahraeus R; Nylander K
J Invest Dermatol; 2015 Aug; 135(8):2077-2083. PubMed ID: 25830654
[TBL] [Abstract][Full Text] [Related]
31. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques.
Johnson-Huang LM; Suárez-Fariñas M; Sullivan-Whalen M; Gilleaudeau P; Krueger JG; Lowes MA
J Invest Dermatol; 2010 Nov; 130(11):2654-63. PubMed ID: 20555351
[TBL] [Abstract][Full Text] [Related]
32. Effect of NB-UVB on levels of MCP-1 and CCR6 mRNA in patients with psoriasis vulgaris.
Gao ML; Wang AG
Genet Mol Res; 2015 Oct; 14(4):12137-44. PubMed ID: 26505361
[TBL] [Abstract][Full Text] [Related]
33. Laser Doppler perfusion imaging (LDPI) and transepidermal water loss (TEWL) values in psoriatic lesions treated with narrow band UVB phototherapy. Dermal vascularity may be useful indicator of psoriatic activity.
Goh CL; Khoo L
Ann Acad Med Singap; 2004 Jan; 33(1):75-9. PubMed ID: 15008568
[TBL] [Abstract][Full Text] [Related]
34. Local effects of TL01 phototherapy in psoriasis.
DeSilva B; McKenzie RC; Hunter JA; Norval M
Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):268-9. PubMed ID: 18811869
[TBL] [Abstract][Full Text] [Related]
35. Remission period in psoriasis after multiple cycles of narrowband ultraviolet B phototherapy.
Ryu HH; Choe YS; Jo S; Youn JI; Jo SJ
J Dermatol; 2014 Jul; 41(7):622-7. PubMed ID: 24942986
[TBL] [Abstract][Full Text] [Related]
36. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis?
Pavlovsky M; Baum S; Shpiro D; Pavlovsky L; Pavlotsky F
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):727-9. PubMed ID: 20726938
[TBL] [Abstract][Full Text] [Related]
37. Impact of NB-UVB phototherapy on Caveolin-1 expression in chronic plaque psoriasis.
Elsherbeni MB; Neinaa YME; Fawzy MM; Elwan NM
Photodermatol Photoimmunol Photomed; 2023 May; 39(3):218-225. PubMed ID: 35860958
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of systemic oxidant/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy.
Pektas SD; Akoglu G; Metin A; Neselioglu S; Erel O
Redox Rep; 2013; 18(5):200-4. PubMed ID: 24020719
[TBL] [Abstract][Full Text] [Related]
39. Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation.
Weatherhead SC; Farr PM; Jamieson D; Hallinan JS; Lloyd JJ; Wipat A; Reynolds NJ
J Invest Dermatol; 2011 Sep; 131(9):1916-26. PubMed ID: 21614017
[TBL] [Abstract][Full Text] [Related]
40. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
Park KK; Wu JJ; Koo J
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
